Global Information
회사소개 | 문의

세계의 줄기세포 어세이 시장 예측

Global Stem Cell Assay Market Forecast 2019-2027

리서치사 Inkwood Research
발행일 2019년 03월 상품 코드 484189
페이지 정보 영문 120 Pages
가격
US $ 2,500 ₩ 2,857,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,428,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. PDF 파일은 Copy & Paste가 되지 않습니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,143,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 줄기세포 어세이 시장 예측 Global Stem Cell Assay Market Forecast 2019-2027
발행일 : 2019년 03월 페이지 정보 : 영문 120 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 줄기세포 어세이(Stem Cell Assay) 시장에 대해 분석했으며, 시장의 기본적 구조, 시장 성장에 대한 각종 영향요인, 시장 동향과 향후 전망, 종류·제품·키트·용도·최종사용자·지역별 동향, 경쟁 구도, 시장 발전 방향성, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 개요

  • 시장 성장 촉진요인
  • 시장 성장 저해요인
  • 시장 기회
  • 시장이 해결해야 할 과제

제5장 세계의 줄기세포 어세이 시장 : 시장 세분화

  • 종류별
    • 세포 생존률과 세포 독성 어세이
    • 분리/정제 어세이
    • 세포 식별 어세이
    • 세포 분화 어세이
    • 세포 기능 어세이
    • 세포 아포토시스 어세이
  • 제품별
    • 기구
    • 검출 키트
  • 키트별
    • 성체줄기세포 키트
    • 인간배아줄기세포 키트
  • 용도별
    • 재생 의료 및 치료
    • Drug Discovery And Development
    • 임상 조사
  • 최종사용자별
    • 조사기관
    • 산업 연구

제6장 주요 분석

  • Porter's Five Forces 분석
  • PESTEL 분석
  • 시장 기회 지표
  • 구매 기준
    • 가격 설정
    • 유효성
    • 정확성
  • 전략 제안과 결론
  • 벤더 개요
  • 밸류체인 분석

제7장 세계의 줄기세포 어세이 시장 : 지역 분석

  • 북미 시장
  • 유럽 시장
  • 아시아태평양 지역 시장
  • 기타 시장

제8장 기업 개요

KSM 17.04.20

KEY FINDINGS

The global stem cell assay market is anticipated to generate revenue of $3188.4 million by 2027 and grow at a CAGR of 18.05% between 2019 and 2027. Growing investment in the research activities is the key factor intensifying the growth of the stem cell assay. Stem cells are extensively investigated owing to their regenerative potentials. The increasing adoption of stem cell assay for drug screening & testing is one of the major factors that is primarily driving the industry research market.

MARKET INSIGHTS

The global stem cell assay market is segmented on the basis of types of assay, product, kits, application, end-user, and geography. Increased adoption of stem cell assay, augmenting technology, expense in stem cell research are majorly driving the market growth. The rising adoption of stem cell assay for drug screening & testing is one of the major reasons driving the industry research market.

The applications and types of the assay of stem cell assay market are used extensively for various purposes. The regenerative medicines & therapy development market is expected to dominate the global stem cell assay market. Regenerative medicine helps the natural remedial processes which work more effectively and more quickly.

REGIONAL INSIGHTS

The stem cell assay market by geography is segmented into North America, Europe, Asia-Pacific and the Rest of World. North America held the colossal markets share of xx% in 2018 in the global stem cell market. The growth in the North America stem cell assay market is mainly driven by the growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and rise in the research and development spending in the biotechnology sector.

The APAC region is anticipated to grow at a faster rate. The growing prevalence of chronic diseases such as cancer, cardiovascular disorders, etc. that have become the crucial development driver of the Asia Pacific market.

The Europe stem cell assay market is mainly driven by the rising prevalence of chronic disorders such as cancer and cardiovascular disorders. Moreover, the rising healthcare spending is also boosting the growth in the Europe stem cell assay market.

COMPETITIVE INSIGHTS

Stem Cell Technologies, Fibrocell Science Inc., Corning Inc., GE Healthcare, Becton Dickinson, Stryker Corporation, R&D Systems, Thermo Fisher, Cellular Dynamics International (Holding Company Fujifilm), Promega Corporation, Hemogenix Inc., Cell Bio Labs, Inc., Merck Millipore (holding company is Merck KGaA), Takara Holdings Inc. and Bio-Rad are the major market players.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. INDUSTRY RESEARCH IS THE LEADING END-USER SEGMENT
    • 3.2.2. INCREASING DEMAND FOR REGENERATIVE MEDICINE
    • 3.2.3. CELL VIABILITY & TOXICITY ASSAYS ARE MAJORLY USED
    • 3.2.4. ADULT STEM CELL KITS ARE THE FASTEST GROWING STEM CELL KIT

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISING ADOPTION OF STEM CELL ASSAY
    • 4.2.2. TECHNOLOGICAL ADVANCEMENT
    • 4.2.3. GROWING SPENDING IN STEM CELL RESEARCH
    • 4.2.4. POTENTIAL OF STEM CELLS IN REGENERATIVE MEDICINE
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST FOR TREATMENT
    • 4.3.2. SLOW RESPONSE TIME OF REGULATORY BODIES
    • 4.3.3. ETHICAL CONCERN RELATED TO STEM CELL RESEARCH
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. CHANGING MARKET DYNAMICS
    • 4.4.2. EMERGING APPLICATION AS A DRUG DISCOVERY TOOL
  • 4.5. MARKET CHALLENGES
    • 4.5.1. ISSUE RELATED TO THE PATIENT'S IMMUNE SYSTEM
    • 4.5.2. STRINGENT GOVERNMENT REGULATIONS

5. MARKET BY TYPE OF ASSAY

  • 5.1. CELL VIABILITY & TOXICITY ASSAYS
  • 5.2. ISOLATION/PURIFICATION ASSAYS
  • 5.3. CELL IDENTIFICATION ASSAYS
  • 5.4. CELL DIFFERENTIATION ASSAYS
  • 5.5. CELL FUNCTION ASSAYS
  • 5.6. CELL APOPTOSIS ASSAYS

6. MARKET BY PRODUCT

  • 6.1. INSTRUMENTS
  • 6.2. DETECTION KIT

7. MARKET BY KITS

  • 7.1. ADULT STEM CELL KIT
    • 7.1.1. MESENCHYMAL STEM CELL KIT
    • 7.1.2. INDUCED PLURIPOTENT STEM CELL KIT
    • 7.1.3. HEMATOPOIETIC STEM CELL KIT
    • 7.1.4. NEURONAL STEM CELL KIT
    • 7.1.5. UMBILICAL CORD STEM CELL KIT
  • 7.2. HUMAN EMBRYONIC STEM CELL KIT
    • 7.2.1. REGENERATIVE MEDICINE
    • 7.2.2. STEM CELL BIOLOGY RESEARCH
    • 7.2.3. TISSUE ENGINEERING
    • 7.2.4. TOXICOLOGY TESTING

8. MARKET BY APPLICATION

  • 8.1. REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET
    • 8.1.1. ORTHOPEDIC & MUSCULOSKELETAL SPINE
    • 8.1.2. DERMATOLOGY
    • 8.1.3. CARDIOVASCULAR
    • 8.1.4. CENTRAL NERVOUS SYSTEM
    • 8.1.5. ONCOLOGY
  • 8.2. DRUG DISCOVERY & DEVELOPMENT MARKET
  • 8.3. CLINICAL RESEARCH

9. MARKET BY END-USER

  • 9.1. RESEARCH INSTITUTES
  • 9.2. INDUSTRY RESEARCH

10. KEY ANALYTICS

  • 10.1. PORTER'S FIVE FORCE MODEL
    • 10.1.1. THREAT OF NEW ENTRANTS
    • 10.1.2. THREAT OF SUBSTITUTE
    • 10.1.3. BARGAINING POWER OF BUYER
    • 10.1.4. BARGAINING POWER OF SUPPLIER
    • 10.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 10.2. KEY BUYING CRITERIA
    • 10.2.1. PRICING
    • 10.2.2. EFFICACY
    • 10.2.3. ACCURACY
  • 10.3. VALUE CHAIN ANALYSIS
  • 10.4. PEST ANALYSIS
  • 10.5. PATENT ANALYSIS
    • 10.5.1. NORTH AMERICA PATENT ANALYSIS
    • 10.5.2. EUROPE PATENT ANALYSIS
    • 10.5.3. ASIA PACIFIC PATENT ANALYSIS
  • 10.6. REGULATORY FRAMEWORK
  • 10.7. OPPORTUNITY MATRIX

11. GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1. THE UNITED STATES
    • 11.1.2. CANADA
  • 11.2. EUROPE
    • 11.2.1. THE UNITED KINGDOM
    • 11.2.2. GERMANY
    • 11.2.3. FRANCE
    • 11.2.4. ITALY
    • 11.2.5. SPAIN
    • 11.2.6. REST OF EUROPE
  • 11.3. ASIA-PACIFIC
    • 11.3.1. INDIA
    • 11.3.2. CHINA
    • 11.3.3. JAPAN
    • 11.3.4. SOUTH KOREA
    • 11.3.5. AUSTRALIA
    • 11.3.6. REST OF ASIA-PACIFIC
  • 11.4. REST OF WORLD
    • 11.4.1. LATIN AMERICA
    • 11.4.2. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

    • 12.1.1. MARKET SHARE ANALYSIS
  • 12.2. COMPANY PROFILES
    • 12.2.1. BECTON DICKINSON
      • 12.2.1.1. COMPANY OVERVIEW
      • 12.2.1.2. PRODUCT PORTFOLIO
      • 12.2.1.3. SCOT ANALYSIS
      • 12.2.1.4. STRATEGIC INITIATIVES
    • 12.2.2. BIO-RAD
      • 12.2.2.1. COMPANY OVERVIEW
      • 12.2.2.2. PRODUCT PORTFOLIO
      • 12.2.2.3. SCOT ANALYSIS
      • 12.2.2.4. STRATEGIC INITIATIVES
    • 12.2.3. CELL BIO LABS, INC.
      • 12.2.3.1. COMPANY OVERVIEW
      • 12.2.3.2. PRODUCT PORTFOLIO
      • 12.2.3.3. SCOT ANALYSIS
    • 12.2.4. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
      • 12.2.4.1. COMPANY OVERVIEW
      • 12.2.4.2. PRODUCT PORTFOLIO
      • 12.2.4.3. SCOT ANALYSIS
      • 12.2.4.4. STRATEGIC INITIATIVES
    • 12.2.5. CORNING INC.
      • 12.2.5.1. COMPANY OVERVIEW
      • 12.2.5.2. PRODUCT PORTFOLIO
      • 12.2.5.3. SCOT ANALYSIS
      • 12.2.5.4. STRATEGIC INITIATIVES
    • 12.2.6. FIBROCELL SCIENCE INC.
      • 12.2.6.1. COMPANY OVERVIEW
      • 12.2.6.2. PRODUCT PORTFOLIO
      • 12.2.6.3. SCOT ANALYSIS
      • 12.2.6.4. STRATEGIC INITIATIVES
    • 12.2.7. GE HEALTHCARE
      • 12.2.7.1. COMPANY OVERVIEW
      • 12.2.7.2. PRODUCT PORTFOLIO
      • 12.2.7.3. SCOT ANALYSIS
      • 12.2.7.4. STRATEGIC INITIATIVES
    • 12.2.8. HEMOGENIX INC.
      • 12.2.8.1. COMPANY OVERVIEW
      • 12.2.8.2. PRODUCT PORTFOLIO
      • 12.2.8.3. SCOT ANALYSIS
    • 12.2.9. MERCK MILLIPORE (HOLDING COMPANY IS MERCK KGAA)
      • 12.2.9.1. COMPANY OVERVIEW
      • 12.2.9.2. PRODUCT PORTFOLIO
      • 12.2.9.3. SCOT ANALYSIS
      • 12.2.9.4. STRATEGIC INITIATIVES
    • 12.2.10. PROMEGA CORPORATION
      • 12.2.10.1. COMPANY OVERVIEW
      • 12.2.10.2. PRODUCTS PORTFOLIO
      • 12.2.10.3. SCOT ANALYSIS
      • 12.2.10.4. STRATEGIC INITIATIVES
    • 12.2.11. R&D SYSTEMS
      • 12.2.11.1. COMPANY OVERVIEW
      • 12.2.11.2. PRODUCT PORTFOLIO
      • 12.2.11.3. SCOT ANALYSIS
    • 12.2.12. STEM CELL TECHNOLOGIES
      • 12.2.12.1. COMPANY OVERVIEW
      • 12.2.12.2. PRODUCT PORTFOLIO
      • 12.2.12.3. SCOT ANALYSIS
      • 12.2.12.4. STRATEGIC INITIATIVES
    • 12.2.13. STRYKER CORPORATION
      • 12.2.13.1. COMPANY OVERVIEW
      • 12.2.13.2. PRODUCT PORTFOLIO
      • 12.2.13.3. SCOT ANALYSIS
      • 12.2.13.4. STRATEGIC INITIATIVES
    • 12.2.14. TAKARA HOLDINGS INC.
      • 12.2.14.1. COMPANY OVERVIEW
      • 12.2.14.2. PRODUCT PORTFOLIO
      • 12.2.14.3. SCOT ANALYSIS
      • 12.2.14.4. STRATEGIC INITIATIVES
    • 12.2.15. THERMO FISHER
      • 12.2.15.1. COMPANY OVERVIEW
      • 12.2.15.2. PRODUCT PORTFOLIO
      • 12.2.15.3. SCOT ANALYSIS
      • 12.2.15.4. STRATEGIC INITIATIVES

TABLE LIST

  • TABLE 1 GLOBAL STEM CELL ASSAY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2 GLOBAL STEM CELL ASSAY MARKET BY TYPE OF ASSAY 2019-2027 ($ MILLION)
  • TABLE 3 GLOBAL CELL VIABILITY & TOXICITY ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 4 GLOBAL ISOLATION/PURIFICATION ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL CELL IDENTIFICATION ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL CELL DIFFERENTIATION ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL CELL FUNCTION ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL CELL APOPTOSIS ASSAYS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 9 GLOBAL STEM CELL ASSAY MARKET BY PRODUCT 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL INSTRUMENTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11 GLOBAL DETECTION KIT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 12 GLOBAL STEM CELL ASSAY MARKET BY KITS 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL ADULT STEM CELL KIT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL ADULT STEM CELL KIT MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 15 GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 16 GLOBAL STEM CELL ASSAY MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 17 GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 18 GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 19 GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 20 GLOBAL CLINICAL RESEARCH BY REGION 2019-2027 ($ MILLION)
  • TABLE 21 GLOBAL STEM CELL ASSAY MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 22 GLOBAL RESEARCH INSTITUTES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 23 RESEARCH ACTIVITIES ON DIFFERENT TYPE OF STEM CELLS
  • TABLE 24 GLOBAL INDUSTRY RESEARCH MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 25 GLOBAL STEM CELL ASSAY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 26 NORTH AMERICA STEM CELL ASSAY MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 27 EUROPE STEM CELL ASSAY MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 28 ASIA-PACIFIC STEM CELL ASSAY MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 29 STEM CELL RESEARCH POLICIES IN SOME ASIAN COUNTRIES
  • TABLE 30 REST OF WORLD STEM CELL ASSAY MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURES LIST

  • FIGURE 1 GLOBAL STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 GLOBAL STEM CELL ASSAY MARKET SHARE BY TYPE OF ASSAY 2018 & 2027 (%)
  • FIGURE 3 GLOBAL STEM CELL ASSAY MARKET BY CELL VIABILITY & TOXICITY ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 4 GLOBAL STEM CELL ASSAY MARKET BY ISOLATION/PURIFICATION ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL STEM CELL ASSAY MARKET BY CELL IDENTIFICATION ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 6 GLOBAL STEM CELL ASSAY MARKET BY CELL DIFFERENTIATION ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL STEM CELL ASSAY MARKET BY CELL FUNCTION ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL STEM CELL ASSAY MARKET BY CELL APOPTOSIS ASSAYS 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL STEM CELL ASSAY MARKET SHARE BY PRODUCT 2018 & 2027 (%)
  • FIGURE 10 GLOBAL STEM CELL ASSAY MARKET BY INSTRUMENTS 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL STEM CELL ASSAY MARKET BY DETECTION KIT 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL STEM CELL ASSAY MARKET SHARE BY TYPE OF ASSAY 2018 & 2027 (%)
  • FIGURE 13 GLOBAL STEM CELL ASSAY MARKET BY ADULT STEM CELL KIT 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL ADULT STEM CELL KIT MARKET BY MESENCHYMAL STEM CELL KIT 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL ADULT STEM CELL KIT MARKET BY INDUCED PLURIPOTENT STEM CELL KIT 2019-2027 ($ MILLION)
  • FIGURE 16 GLOBAL ADULT STEM CELL KIT MARKET BY HEMATOPOIETIC STEM CELL KIT 2019-2027 ($ MILLION)
  • FIGURE 17 GLOBAL ADULT STEM CELL KIT MARKET BY NEURONAL STEM CELL KIT 2019-2027 ($ MILLION)
  • FIGURE 18 GLOBAL ADULT STEM CELL KIT MARKET BY UMBILICAL CORD STEM CELL KIT 2019-2027 ($ MILLION)
  • FIGURE 19 GLOBAL STEM CELL ASSAY MARKET BY HUMAN EMBRYONIC STEM CELL KIT 2019-2027 ($ MILLION)
  • FIGURE 20 GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY REGENERATIVE MEDICINE 2019-2027 ($ MILLION)
  • FIGURE 21 GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY STEM CELL BIOLOGY RESEARCH 2019-2027 ($ MILLION)
  • FIGURE 22 GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY TISSUE ENGINEERING 2019-2027 ($ MILLION)
  • FIGURE 23 GLOBAL HUMAN EMBRYONIC STEM CELL KIT MARKET BY TOXICOLOGY TESTING 2019-2027 ($ MILLION)
  • FIGURE 24 GLOBAL STEM CELL ASSAY MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 25 GLOBAL STEM CELL ASSAY MARKET BY REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET 2019-2027 ($ MILLION)
  • FIGURE 26 GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY ORTHOPEDIC & MUSCULOSKELETAL SPINE 2019-2027 ($ MILLION)
  • FIGURE 27 GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY DERMATOLOGY 2019-2027 ($ MILLION)
  • FIGURE 28 GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY CARDIOVASCULAR 2019-2027 ($ MILLION)
  • FIGURE 29 GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY CENTRAL NERVOUS SYSTEM 2019-2027 ($ MILLION)
  • FIGURE 30 GLOBAL REGENERATIVE MEDICINES & THERAPY DEVELOPMENT MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
  • FIGURE 31 GLOBAL STEM CELL ASSAY MARKET BY DRUG DISCOVERY & DEVELOPMENT MARKET 2019-2027 ($ MILLION)
  • FIGURE 32 GLOBAL STEM CELL ASSAY MARKET BY CLINICAL RESEARCH 2019-2027 ($ MILLION)
  • FIGURE 33 GLOBAL STEM CELL ASSAY MARKET SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 34 GLOBAL STEM CELL ASSAY MARKET BY RESEARCH INSTITUTES MARKET 2019-2027 ($ MILLION)
  • FIGURE 35 GLOBAL STEM CELL ASSAY MARKET BY INDUSTRY RESEARCH MARKET 2019-2027 ($ MILLION)
  • FIGURE 36 PORTER'S FIVE FORCE MODEL
  • FIGURE 37 GLOBAL STEM CELL ASSAY MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 38 THE UNITED STATES STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 39 CANADA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 40 THE UNITED KINGDOM STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 41 GERMANY STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 42 FRANCE STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 43 ITALY STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 44 SPAIN STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 45 REST OF EUROPE STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 46 INDIA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 47 CHINA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 48 JAPAN STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 49 SOUTH KOREA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 50 AUSTRALIA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 51 REST OF ASIA-PACIFIC STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 52 LATIN AMERICA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 53 MIDDLE EAST AND AFRICA STEM CELL ASSAY MARKET 2019-2027 ($ MILLION)
  • FIGURE 54 STEM CELL ASSAY MARKET SHARE ANALYSIS OF KEY PLAYERS 2018 (%)
Back to Top
전화 문의
F A Q
 
BCC Research